WITTINGTON INVESTMENTS / FAIRFAX FINANCIAL take majority stake in BOOTS
Context
Wittington Investments and Fairfax Financial agreed to acquire Boots from Sycamore Partners and the Pessina family for a total purchase consideration of $1–10bn, including assumed debt, implying an EV/EBITDA multiple of 5x–12x. The transaction covers Boots' retail operations in the UK and Ireland, Boots Opticians, No7 Beauty Company, and its Thailand and franchised businesses. Sycamore Partners and Stefano Pessina's family were to retain the group's other interests, including Farmacias Benavides and Alliance Healthcare Deutschland. Boots reported revenue of $1–10bn and EBITDA of $450–900M for the financial year ended in August, corresponding to an EBITDA margin of [members only]. The business employed more than 50,000 colleagues and had been re-established as a standalone company by Sycamore Partners the previous year. Following completion, Wittington and Fairfax were each to hold a 50% stake, with Wittington responsible for operational control. Galen Weston, Wittington's chairman, was expected to become chairman of Boots, while Fairfax committed up to approximately $ 2.3 billion towards the purchase price. The transaction was expected to close in the first quarter of 2027, subject to customary closing conditions, including antitrust approvals and clearances. CIBC Capital Markets and Morgan Stanley Canada acted as lead financial advisers to Wittington, alongside RBC Capital Markets and Barclays. Skadden, Arps, Slate, Meagher & Flom and A&O Shearman provided legal advice, while CIBC and Morgan Stanley Senior Funding acted as lead arrangers and provided acquisition financing. UBS Investment Bank and Rothschild & Co. led the financial advisory team for The Boots Group, alongside J.P. Morgan, Citi, Deutsche Bank Securities and Goldman Sachs, with Davis Polk & Wardwell serving as legal adviser. A&O Shearman also advised Fairfax, with its team led by M&A partners Sean Skiffington in Toronto and Nick Withers in London.
-> Deep-dive in Healthcare & Pharma market trends
Target
Founded in the nineteenth century, Boots is a pharmacy-led health and beauty retailer operating in the United Kingdom and Ireland. The company runs retail stores across both countries, together with its Boots Opticians business and the No7 Beauty Company brand portfolio. Its Thailand operations and franchised businesses extend the banner beyond its home markets. The offer combines in-store pharmacy and health services with beauty and personal care ranges sold under proprietary brands, including No7. Customers are individual consumers and patients who turn to Boots for health and beauty needs. The company is headquartered in the United Kingdom, with retail and optician outlets located across the UK and Ireland and additional activity in Thailand through franchised arrangements.
Ent. Value
$1–10bn
Equity Value
[members only]
Multiples
EV / Revenue
below 1.5x
EV / EBITDA
5x–12x
EV / EBIT
[members only]
Historical Financials (USD)
Similar deals in Health Providers
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2026 | BRIDGEPOINT | ALTANO | GERMANY | Vet Clinics |
| 06/2026 | STAR CAPITAL | Glenholme Specialist Care | UNITED KINGDOM | Nursing Homes |
| 05/2026 | JARDINE MATHESON | I-MED RADIOLOGY NETWORK | AUSTRALIA | Radiology |
| 05/2026 | MEHILÄINEN GROUP | ALERIS | SWEDEN | Clinics / Hospitals |
| 05/2026 | Kinderhook Industries | Enhabit | UNITED STATES | Clinics / Hospitals |
| 05/2026 | STONEPEAK | ESTIA HEALTH | AUSTRALIA | Nursing Homes |
| 04/2026 | COLOSSEUM DENTAL GROUP | MEDICALSAN | ITALY | Dental Centers |
| 02/2026 | MERIEUX EQUITY PARTNERS | HEALTH IN CODE (HIC) | SPAIN | Labs (Biology) |
| 01/2026 | GTCR | DENTALCORP | Canada | Dental Centers |
| 01/2026 | POINT VISION | CLINIQUE DE LA VISION (REFRACT SAS) | FRANCE | Ophthalmology |
REFERENCES
Valuation range: EV $1–10bn
Revenue range: $1–10bn
EBITDA range: $450–900M
EV/Revenue range: below 1.5x
EV/EBITDA range: 5x - 12x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of BOOTS by WITTINGTON INVESTMENTS / FAIRFAX FINANCIAL are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Target: boots
Acquirer: fairfax financial / wittington investments